Blood or hematologic cancers affect the blood, bone marrow, or lymphatic system. These types of cancers are challenging to detect and treat, as they show varying symptoms that can easily be confused with other illnesses. Blood cancers, such as leukaemia, lymphoma, and multiple myeloma, are becoming increasingly common in India due to a variety of factors, and it is crucial to understand how they are diagnosed and treated. In this blog post, we delve into how the American Oncology Institute (AOI), Hyderabad, provides world-class diagnosis and treatment for blood cancers.
At AOI, Hyderabad, the diagnosis of blood cancers involves a comprehensive evaluation of a patient's symptoms, medical history, and family history. Blood tests, imaging, molecular, and biopsies are used primarily to diagnose blood cancers. The tests used depend on the type of cancer and the severity of the symptoms. Diagnosis is a crucial stage that determines the course of treatment. AOI has state-of-the-art diagnostic facilities that complement the expertise of its experienced and trained oncologists and haematologists.
Treatment techniques for blood cancer depend on the subtype and factors such as the stage, age, and overall health of the patient. At AOI, Hyderabad, the treatment approach for blood cancers is personalized and aims to provide the best possible outcomes for patients. The main treatment options are chemotherapy, radiation therapy, targeted therapy, bone marrow transplant, and immunotherapy. AOI uses advanced technology, such as second-generation sequencing and gene expression profiling, to determine the best treatment options for their patients.
Leukaemia is a type of blood cancer that starts in the bone marrow and produces abnormal blood cells. Leukaemia treatment is based on the subtype of the disease, stage, response to previous therapy, and the age and overall health of the patient. In specific cases, AOI uses a surgical procedure known as leukapheresis to treat some patients with high white blood cell counts. This procedure involves removing white blood cells from the bloodstream, which helps to reduce the risk of developing organ damage.
Lymphoma cancer is a type of blood cancer that results when the lymphatic system is affected. The two main subtypes are Hodgkin's lymphoma and Non-Hodgkin's lymphoma. Treatment for lymphoma varies and combines radiation therapy with chemotherapy. In advanced cases, stem cell transplant is an option. AOI provides the latest treatments in lymphoma cancer management to ensure optimal outcomes.
Multiple myeloma is a type of blood cancer that affects plasma cells. As the disease progresses, the patient's bone marrow produces increasingly abnormal and malignant plasma cells. The team of experienced oncologists at AOI specializes in treating multiple myeloma with therapies, such as immunomodulatory drugs and targeted therapy.
In conclusion, treating blood cancers requires an individualized approach to provide the best possible outcomes. Blood cancer diagnosis and treatment require a team of experienced and trained haematologists and oncologists, state-of-the-art diagnostic and treatment facilities, and advanced technology. AOI provides comprehensive and personalized care using global treatment standards, enabling patients with blood cancers to achieve the best possible health outcomes.
